Lead poisoning due to adulterated marijuana in leipzig.

The Public Health Framework of Legalized Marijuana in Colorado. Am J Public Health (2015) 0.84

Incorrectly cited. Dtsch Arztebl Int (2009) 0.75

Indication for chelator therapy should be defined critically. Dtsch Arztebl Int (2009) 0.75

Evaluation of blood lead level in methamphetamine users in Tehran. Subst Abuse Treat Prev Policy (2017) 0.75

Indicative of intoxication. Dtsch Arztebl Int (2009) 0.75

Low-level environmental lead exposure and children's intellectual function: an international pooled analysis. Environ Health Perspect (2005) 10.66

Recommendations for medical management of adult lead exposure. Environ Health Perspect (2006) 3.38

Lead poisoning. Annu Rev Med (2004) 3.31

Lead toxicity, a review of the literature. Part 1: Exposure, evaluation, and treatment. Altern Med Rev (2006) 2.29

Impairment of renal function with increasing blood lead concentrations in the general population. The Cadmibel Study Group. N Engl J Med (1992) 2.17

Blood lead levels and death from all causes, cardiovascular disease, and cancer: results from the NHANES III mortality study. Environ Health Perspect (2006) 2.07

The epidemiology of lead toxicity in adults: measuring dose and consideration of other methodologic issues. Environ Health Perspect (2006) 1.91

Blood lead levels and mortality. Arch Intern Med (2002) 1.86

Lead toxicity and chelation therapy. Am J Health Syst Pharm (2007) 1.74

Lead, blood pressure, and cardiovascular disease in men. Arch Environ Health (1995) 1.72

House dust as possible route of environmental exposure to cadmium and lead in the adult general population. Environ Res (2006) 1.59

Occupational exposure to lead compounds and risk of cancer among men: a population-based case-control study. Am J Epidemiol (2007) 1.55

Lead toxicity part II: the role of free radical damage and the use of antioxidants in the pathology and treatment of lead toxicity. Altern Med Rev (2006) 1.48

An epidemiological re-appraisal of the association between blood pressure and blood lead: a meta-analysis. J Hum Hypertens (2002) 1.40

Cancer and occupational exposure to inorganic lead compounds: a meta-analysis of published data. Occup Environ Med (1995) 1.39

Burton's line in lead poisoning. Eur Neurol (2006) 1.34

Lead poisoning during heroin addiction. Ital J Neurol Sci (1989) 1.32

Lead toxicity update. A brief review. Med Sci Monit (2005) 1.32

Environmental exposure to lead and progression of chronic renal diseases: a four-year prospective longitudinal study. J Am Soc Nephrol (2004) 1.30

Increased body lead burden--cause or consequence of chronic renal insufficiency? N Engl J Med (2003) 1.27

Childhood lead poisoning. Pediatr Clin North Am (2002) 1.24

Lead poisoning, haem synthesis and 5-aminolaevulinic acid dehydratase. Trends Biochem Sci (1998) 1.21

Abdominal pain due to lead-contaminated opium: a new source of inorganic lead poisoning in Iran. Arch Iran Med (2006) 1.20

Childhood lead poisoning: the torturous path from science to policy. J Clin Invest (2006) 1.13

Lead exposure among small-scale battery recyclers, automobile radiator mechanics, and their children in Manila, the Philippines. Environ Res (2000) 1.07

Lead poisoning due to adulterated marijuana. N Engl J Med (2008) 0.99

[Lead poisoning due to drug addiction: a new source of poisoning with clinical interest and important epidemiological consequences]. An Med Interna (1989) 0.99

Acute lead poisoning: Five cases resulting from self-injection of lead and opium. Q J Med (1975) 0.98

Hypertension caused by low-level lead exposure: myth or fact? J Cardiovasc Risk (1994) 0.97

Acute inhalation injury. Clin Chest Med (2002) 0.96

Different mechanisms mediate uptake of lead in a rat astroglial cell line. Toxicol Sci (2004) 0.93

Lead-contaminated heroin as a source of inorganic-lead intoxication. N Engl J Med (1987) 0.91

Lead poisoning in a drug addict; the intravenous injection of suppository extracts. Br J Clin Pract (1983) 0.89

[An unusual mechanism of lead poisoning. Presentation of a case]. Recenti Prog Med (1989) 0.86

[Goya, Fortuny, Van Gogh, Portinari: lead poisoning in painters across three centuries]. Rev Clin Esp (2006) 0.85

Blood lead of intravenous drug users. J Toxicol Clin Toxicol (1996) 0.84

Rembrandt--aging and sickness: a combined look by plastic surgeons, an art researcher and an internal medicine specialist. Isr Med Assoc J (2007) 0.84

[Lead poisoning and drug addiction]. Rev Clin Esp (1987) 0.82

[A case of lead poisoning in a drug addict. Observations on etiopathogenetic peculiarities]. Clin Ter (1988) 0.81

From the Centers for Disease Control. Lead poisoning associated with intravenous-methamphetamine use--Oregon, 1988. JAMA (1990) 0.81

On a remarkable effect on the human gums, produced by the absorption of lead. Med Chir Trans (1840) 0.80

Subclinical effects of chronic increased lead absorption--a prospective study. Part IV. Evaluation of heme synthesis effects. J Occup Med (1982) 0.79

Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet (2010) 23.08

Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature (2010) 20.01

New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet (2010) 17.89

Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet. N Engl J Med (2008) 12.41

Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution. Nat Genet (2010) 7.94

Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge. Nat Genet (2010) 6.66

Sequence variants at CHRNB3-CHRNA6 and CYP2A6 affect smoking behavior. Nat Genet (2010) 6.49

New loci associated with kidney function and chronic kidney disease. Nat Genet (2010) 5.58

Antioxidants prevent health-promoting effects of physical exercise in humans. Proc Natl Acad Sci U S A (2009) 5.19

Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways. Nat Genet (2012) 4.73

A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance. Nat Genet (2012) 4.37

Common variants at 10 genomic loci influence hemoglobin A₁(C) levels via glycemic and nonglycemic pathways. Diabetes (2010) 4.07

Effects of Initiating Moderate Alcohol Intake on Cardiometabolic Risk in Adults With Type 2 Diabetes: A 2-Year Randomized, Controlled Trial. Ann Intern Med (2015) 3.78

Insulin-sensitive obesity. Am J Physiol Endocrinol Metab (2010) 3.46

Genome-wide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture. Nat Genet (2013) 3.25

Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals. PLoS Genet (2012) 3.21

New gene functions in megakaryopoiesis and platelet formation. Nature (2011) 3.14

Genome-wide association analyses identify 18 new loci associated with serum urate concentrations. Nat Genet (2012) 3.04

Macrophage infiltration into omental versus subcutaneous fat across different populations: effect of regional adiposity and the comorbidities of obesity. J Clin Endocrinol Metab (2007) 2.81

FTO genotype is associated with phenotypic variability of body mass index. Nature (2012) 2.77

Seventy-five genetic loci influencing the human red blood cell. Nature (2012) 2.77

Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism. Diabetes (2003) 2.71

CUBN is a gene locus for albuminuria. J Am Soc Nephrol (2011) 2.70

Serum retinol-binding protein is more highly expressed in visceral than in subcutaneous adipose tissue and is a marker of intra-abdominal fat mass. Cell Metab (2007) 2.69

Chymotrypsin C (CTRC) variants that diminish activity or secretion are associated with chronic pancreatitis. Nat Genet (2007) 2.48

Detailed physiologic characterization reveals diverse mechanisms for novel genetic Loci regulating glucose and insulin metabolism in humans. Diabetes (2010) 2.44

Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity. Diabetes (2006) 2.40

Plasma visfatin concentrations and fat depot-specific mRNA expression in humans. Diabetes (2005) 2.34

New reference intervals for thyrotropin and thyroid hormones based on National Academy of Clinical Biochemistry criteria and regular ultrasonography of the thyroid. Clin Chem (2005) 2.24

Standardized peptidome profiling of human urine by magnetic bead separation and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Clin Chem (2007) 2.11

Variants in CPA1 are strongly associated with early onset chronic pancreatitis. Nat Genet (2013) 2.10

Serum levels of the adipokine progranulin depend on renal function. Diabetes Care (2012) 2.03

Genome-wide association and genetic functional studies identify autism susceptibility candidate 2 gene (AUTS2) in the regulation of alcohol consumption. Proc Natl Acad Sci U S A (2011) 2.01

Serum vaspin concentrations in human obesity and type 2 diabetes. Diabetes (2007) 1.96

New loci associated with birth weight identify genetic links between intrauterine growth and adult height and metabolism. Nat Genet (2012) 1.90

Serum levels of adipokine retinol-binding protein-4 in relation to renal function. Diabetes Care (2007) 1.85

Standardized assessment of whole body adipose tissue topography by MRI. J Magn Reson Imaging (2005) 1.85

MicroRNA expression in human omental and subcutaneous adipose tissue. PLoS One (2009) 1.81

CFTR, SPINK1, CTRC and PRSS1 variants in chronic pancreatitis: is the role of mutated CFTR overestimated? Gut (2012) 1.77

Effect of a 4 week physical training program on plasma concentrations of inflammatory markers in patients with abnormal glucose tolerance. Eur J Endocrinol (2006) 1.76

A genome-wide association search for type 2 diabetes genes in African Americans. PLoS One (2012) 1.72

ENPP1 variants and haplotypes predispose to early onset obesity and impaired glucose and insulin metabolism in German obese children. J Clin Endocrinol Metab (2006) 1.71

Genome-wide association and functional follow-up reveals new loci for kidney function. PLoS Genet (2012) 1.68

Multiple loci are associated with white blood cell phenotypes. PLoS Genet (2011) 1.65

Relationship of serum adiponectin and leptin concentrations with body fat distribution in humans. Obes Res (2003) 1.65

Effect of increased exercise in school children on physical fitness and endothelial progenitor cells: a prospective randomized trial. Circulation (2009) 1.61

Intramyocellular lipids: anthropometric determinants and relationships with maximal aerobic capacity and insulin sensitivity. J Clin Endocrinol Metab (2003) 1.58

Sepsis-associated changes of the arachidonic acid metabolism and their diagnostic potential in septic patients. Crit Care Med (2012) 1.56

Genetic and functional identification of the likely causative variant for cholesterol gallstone disease at the ABCG5/8 lithogenic locus. Hepatology (2013) 1.53

The cerebrocortical response to hyperinsulinemia is reduced in overweight humans: a magnetoencephalographic study. Proc Natl Acad Sci U S A (2006) 1.51

Serum levels of fibroblast growth factor-21 are increased in chronic and acute renal dysfunction. Clin Endocrinol (Oxf) (2014) 1.49

Standardized approach to proteome profiling of human serum based on magnetic bead separation and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Clin Chem (2005) 1.48

Eigenvector centrality mapping for analyzing connectivity patterns in fMRI data of the human brain. PLoS One (2010) 1.48

Brain activity in hunger and satiety: an exploratory visually stimulated FMRI study. Obesity (Silver Spring) (2008) 1.46

Circulating adipocyte fatty acid-binding protein induces insulin resistance in mice in vivo. Obesity (Silver Spring) (2015) 1.45

Serum levels of the adipokine FGF21 depend on renal function. Diabetes Care (2008) 1.42

Assay-dependent variability of serum insulin levels during oral glucose tolerance test: influence on reference intervals for insulin and on cut-off values for insulin sensitivity indices. Clin Chem Lab Med (2008) 1.42

Serum progranulin concentrations may be associated with macrophage infiltration into omental adipose tissue. Diabetes (2008) 1.42

Multiple symmetric lipomatosis: a paradigm of metabolically innocent obesity? Diabetes Care (2004) 1.42

Sex-dependent influences of obesity on cerebral white matter investigated by diffusion-tensor imaging. PLoS One (2011) 1.30

Vaspin gene expression in human adipose tissue: association with obesity and type 2 diabetes. Biochem Biophys Res Commun (2005) 1.30

Dietary intervention to reverse carotid atherosclerosis. Circulation (2010) 1.28

Association of Pro12Ala polymorphism in peroxisome proliferator-activated receptor gamma with Pre-diabetic phenotypes: meta-analysis of 57 studies on nondiabetic individuals. Diabetes Care (2006) 1.27

Association of FTO variants with BMI and fat mass in the self-contained population of Sorbs in Germany. Eur J Hum Genet (2010) 1.26

Adipokine pattern in subjects with impaired fasting glucose and impaired glucose tolerance in comparison to normal glucose tolerance and diabetes. PLoS One (2010) 1.25

Interleukin-1beta induces the novel adipokine chemerin in adipocytes in vitro. Regul Pept (2009) 1.24

Genetic regulation of serum phytosterol levels and risk of coronary artery disease. Circ Cardiovasc Genet (2010) 1.23

Isoproterenol, TNFalpha, and insulin downregulate adipose triglyceride lipase in 3T3-L1 adipocytes. Mol Cell Endocrinol (2005) 1.20

Acute hyperglycemia causes intracellular formation of CML and activation of ras, p42/44 MAPK, and nuclear factor kappaB in PBMCs. Diabetes (2003) 1.19

Serum levels of the adipokine vaspin in relation to metabolic and renal parameters. J Clin Endocrinol Metab (2007) 1.19

Serum levels of the atherosclerosis biomarker sTWEAK are decreased in type 2 diabetes and end-stage renal disease. Atherosclerosis (2007) 1.18

Two patterns of adipokine and other biomarker dynamics in a long-term weight loss intervention. Diabetes Care (2011) 1.18

Obesity-Related Differences between Women and Men in Brain Structure and Goal-Directed Behavior. Front Hum Neurosci (2011) 1.17

Serum amino acid profiles and their alterations in colorectal cancer. Metabolomics (2011) 1.17

Genetic variation in GPR133 is associated with height: genome wide association study in the self-contained population of Sorbs. Hum Mol Genet (2009) 1.16

Interleukin-6 is a negative regulator of visfatin gene expression in 3T3-L1 adipocytes. Am J Physiol Endocrinol Metab (2005) 1.15

Genetic variation in the Sorbs of eastern Germany in the context of broader European genetic diversity. Eur J Hum Genet (2011) 1.15

Expression of adiponectin receptor mRNA in human skeletal muscle cells is related to in vivo parameters of glucose and lipid metabolism. Diabetes (2004) 1.14

Gene expression of PPARgamma and PGC-1alpha in human omental and subcutaneous adipose tissues is related to insulin resistance markers and mediates beneficial effects of physical training. Eur J Endocrinol (2009) 1.14

Integration of genome-wide association studies with biological knowledge identifies six novel genes related to kidney function. Hum Mol Genet (2012) 1.14

Gene expression of adiponectin receptors in human visceral and subcutaneous adipose tissue is related to insulin resistance and metabolic parameters and is altered in response to physical training. Diabetes Care (2007) 1.13

Intramyocellular lipids and insulin resistance. Diabetes Obes Metab (2004) 1.12

Effects of genetic variation in the human retinol binding protein-4 gene (RBP4) on insulin resistance and fat depot-specific mRNA expression. Diabetes (2007) 1.12

Effects of weight loss and exercise on chemerin serum concentrations and adipose tissue expression in human obesity. Metabolism (2011) 1.11

Long-term exercise training decreases interleukin-6 (IL-6) serum levels in subjects with impaired glucose tolerance: effect of the -174G/C variant in IL-6 gene. Eur J Endocrinol (2008) 1.11

Adipose tissue expression and genetic variants of the bone morphogenetic protein receptor 1A gene (BMPR1A) are associated with human obesity. Diabetes (2009) 1.11

Relationships among age, proinsulin conversion, and beta-cell function in nondiabetic humans. Diabetes (2002) 1.08

The prevalent Glu23Lys polymorphism in the potassium inward rectifier 6.2 (KIR6.2) gene is associated with impaired glucagon suppression in response to hyperglycemia. Diabetes (2002) 1.08

Fatty acids and insulin resistance in muscle and liver. Best Pract Res Clin Endocrinol Metab (2005) 1.08

Genomic insights into the origin of farming in the ancient Near East. Nature (2016) 1.07

Serum levels of adipocyte fatty acid-binding protein (AFABP) are increased in chronic haemodialysis (CD). Clin Endocrinol (Oxf) (2008) 1.07

Adiponectin expression in humans is dependent on differentiation of adipocytes and down-regulated by humoral serum components of high molecular weight. Biochem Biophys Res Commun (2005) 1.06

Mitogen-activated protein kinases, inhibitory-kappaB kinase, and insulin signaling in human omental versus subcutaneous adipose tissue in obesity. Endocrinology (2007) 1.06

Adiponectin, obesity, and cardiovascular disease. Biochimie (2004) 1.05

TCF7L2 gene polymorphisms confer an increased risk for early impairment of glucose metabolism and increased height in obese children. J Clin Endocrinol Metab (2007) 1.04